Compare Li Auto Inc (LI) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Li Auto Inc vs Novo Nordisk A/S — how do they compare? Li Auto Inc trades at $12.62 (market cap $12.28B), while Novo Nordisk A/S trades at $45.93 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 16.9× Li Auto Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Li Auto Inc pays none. Which is the better fit depends on your goals.
| LI | NVO | |
|---|---|---|
Market Cap | $12.28B | $207.85B |
Sector | Consumer Cyclical | Health |
52-Week High | $26.69 | $63.98 |
52-Week Low | $11.74 | $35.29 |
Enterprise Value | $1.11B | $222.55B |
Dividend Yield | — | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Li Auto Inc
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 90,000 EVs in 2021, accounting for about 2.7% of China's passenger new energy vehicle market. Beyond Li One, the company will expand its product line, including both BEVs and PHEVs, to target a broader consumer base.
Read more on LI →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
